Combination vaccine developed for smallpox and anthrax

October 6, 2010 by Lin Edwards, Medical Xpress report

Image credit: Wikipedia.
(PhysOrg.com) -- A new combination vaccine against both smallpox and anthrax has been tested in animal studies and found to be more effective against anthrax than the Emergent BioSolutions Inc. vaccine currently available.

The experimental vaccine, developed by scientists from the US (FDA) and the National Cancer Institute, was tested on rabbits and found to build up immunity to faster and more effectively than the anthrax-only vaccine, BioThrax, sold by Maryland company Emergent BioSolutions Inc., which is the version stockpiled by the US government.

The vaccine was developed from a version of Pfizer’s vaccination that had earlier been demonstrated to be more effective in mice with compromised immune systems. This modified vaccine was developed by National Cancer Institute researcher Liyanage Perera and colleagues by adding a gene to the vaccinia virus with a gene encoding for interleukin-15 (IL-15), which is a molecule that boosts the system and helps clear the smallpox virus from the system.

To this modified vaccine the researchers added a gene from the anthrax bacterium. The researchers say this may make the vaccine safer than the alternative because BioThrax contains small amounts of the anthrax toxin, the protein Protective Antigen A (PA), while the new vaccine contains only the protective antigen.

The vaccine was tested in a single dose in rabbits, with control rabbits being given BioThrax and a further group being given the smallpox vaccination. The combination vaccine protected 33 percent of the rabbits, while only around 10 percent were protected by BioThrax. The vaccine has also been tested on mice and found to be faster-acting than the alternative.

Side effects to smallpox and anthrax vaccines do occur, including severe allergic reactions and brain and heart inflammation, and anthrax vaccines must be given in multiple doses and have a shelf life of only four years. The can be stockpiled in a freeze-dried state and rapidly deployed in the event of a biological attack involving anthrax or smallpox.

According to Perera, the next stage in the research is to test the vaccine against anthrax in monkeys, and if this is successful human tests will follow. If testing is successful, the vaccine is likely to be ready for distribution within two or three years.

Both anthrax and smallpox are deadly diseases that can be turned into biological weapons. Having a single to protect against both, especially one that appears at this stage to work better than either of the single disease vaccines, would be highly advantageous in the aftermath of a bioterrorist attack.

The paper was published in the Proceedings of the National Academy of Sciences (PNAS) and the research was funded by the National Institutes of Health.

More information: Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities, Proceedings of the National Academy of Sciences, Published online before print October 4, 2010, doi:10.1073/pnas.1013083107

Related Stories

Recommended for you

New inflammation inhibitor discovered

November 16, 2018
A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action. By inhibiting a certain protein, the researchers were able ...

Gut hormone and brown fat interact to tell the brain it's time to stop eating

November 15, 2018
Researchers from Germany and Finland have shown that so-called "brown fat" interacts with the gut hormone secretin in mice to relay nutritional signals about fullness to the brain during a meal. The study, appearing November ...

Brain, muscle cells found lurking in kidney organoids grown in lab

November 15, 2018
Scientists hoping to develop better treatments for kidney disease have turned their attention to growing clusters of kidney cells in the lab. One day, so-called organoids—grown from human stem cells—may help repair damaged ...

How the Tasmanian devil inspired researchers to create 'safe cell' therapies

November 15, 2018
A contagious facial cancer that has ravaged Tasmanian devils in southern Australia isn't the first place one would look to find the key to advancing cell therapies in humans.

Researchers discover important connection between cells in the liver

November 15, 2018
University of Minnesota Medical School researchers have made a discovery which could lead to a new way of thinking about how disease pathogenesis in the liver is regulated, which is important for understanding the condition ...

Precision neuroengineering enables reproduction of complex brain-like functions in vitro

November 14, 2018
One of the most important and surprising traits of the brain is its ability to dynamically reconfigure the connections to process and respond properly to stimuli. Researchers from Tohoku University (Sendai, Japan) and the ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

bhiestand
not rated yet Oct 06, 2010
But will it remove the smallpox vaccine scar from my arm?

I kid, I kid, this is a great development if it passes muster. It'll be particularly useful for the military.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.